Total oxidant/antioxidant status in sera of patients with thyroid cancers

Endocrine-Related Cancer

Volumn 18, Issue 6, 2011, Pages 773-782

  Wang, Dong ^a   Feng, Jia Fu ^a   Zeng, Ping ^a   Yang, Yun Hong ^a   Luo, Jun ^a   Yang, Yu Wei ^a  

^a MIANYANG CENTRAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; LIOTHYRONINE; THYROTROPIN;

ADOLESCENT; ADULT; AGED; ANALYTICAL PARAMETERS; ANAPLASTIC DIFFERENTIATED THYROID CANCER; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER RISK; CHILD; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INHIBITION KINETICS; MAJOR CLINICAL STUDY; MALE; MEDULLARY THYROID CANCER; OXIDATION; OXIDATIVE STRESS; OXIDATIVE STRESS INDEX; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; THYROID CANCER; THYROID DISEASE; THYROID FOLLICULAR CARCINOMA; THYROID FUNCTION TEST; THYROID PAPILLARY CARCINOMA; THYROIDITIS; TOTAL ANTIOXIDANT STATUS; TOTAL OXIDANT STATUS;

ADOLESCENT; ADULT; ANTIOXIDANTS; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; THYROID DISEASES; THYROID NEOPLASMS; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE; YOUNG ADULT;

EID: 84862909031     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-11-0230     Document Type: Article

References (35)

1. Abiaka C, Al-Awadi F, Al-Sayer H, Gulshan S, Behbehani A, Farghally M & Simbeye A 2001 Serum antioxidant and cholesterol levels in patients with different types of cancer. Journal of Clinical Laboratory Analysis 15 324-330. (doi:10.1002/jcla.1045)
2. Akinci M, Kosova F, Cetin B, Sepici A, Altan N, Aslan S &Cetin A 2008 Oxidant/antioxidant balance in patients with thyroid cancer. Acta Cirúrgica Brasileira 23 551-554. (doi:10.1590/S0102-86502008000600013)
3. Alkhenizan A & Hafez K 2007 The role of vitamin E in the prevention of cancer: a meta-analysis of randomized controlled trials. Annals of Saudi Medicine 27 409-414. (doi:10.4103/0256-4947.51459)
4. Andryskowski G & Owczarek T 2007 The evaluation of selected oxidative stress parameters in patients with hyperthyroidism. Polskie Archiwum Medycyny Wewnetrznej 117 285-289.
5. Aslan M, Cosar N, Celik H, Aksoy N, Dulger AC, Begenik H, Soyoral YU, Kucukoglu ME & Selek S 2011 Evaluation of oxidative status in patients with hyperthyroidism. Endocrine 40 285-289. (doi:10.1007/s12020-011-9472-3)
6. Aycicek A & Erel O 2007 Total oxidant/antioxidant status in jaundiced newborns before and after phototherapy. Jornal de Pediatria 83 319-322. (doi:10.2223/JPED.1645)
7. Aycicek A, Erel O & Kocyigit A 2005 Decreased total antioxidant capacity and increased oxidative stress in passive smoker infants and their mothers. Pediatrics International 47 635-639. (doi:10.1007/s12020-011-9472-3)
8. Bacic-Vrca V, Skreb F, Cepelak I, Mayer L, Kusic Z & Petres B 2005 The effect of antioxidant supplementation on superoxide dismutase activity, Cu and Zn levels, and total antioxidant status in erythrocytes of patients with Graves'disease. Clinical Chemistry and Laboratory Medicine 43 383-388. (doi:10.1515/CCLM.2005.069)
9. Boelaert K 2009 The association between serum TSH concentration and thyroid cancer. Endocrine-Related Cancer 16 1065-1072. (doi:10.1677/ERC-09-0150)
10. Carmeli E, Bachar A, Barchad S, Morad M & Merrick J 2008 Antioxidant status in the serum of persons with intellectual disability and hypothyroidism: a pilot study. Research in Developmental Disabilities 29 431-438. (doi:10.1016/j.ridd.2007.08.001)
11. Coria MJ, Pastrán AI & Gimenez MS 2009 Serum oxidative stress parameters of women with hypothyroidism. Acta Bio-Medica 80 135-139.
12. Du ZX, Zhang HY, Meng X, Guan Y & Wang HQ 2009 Role of oxidative stress and intracellular glutathione in the sensitivity to apoptosis induced by proteasome inhibitor in thyroid cancer cells. BMC Cancer 9 56-67. (doi:10.1186/1471-2407-9-56)
13. Erdamar H, Demirci H, Yaman H, Erbil MK, Yakar T, Sancak B, Elbeg S, Biberoǧlu G & Yetkin I 2008 The effect of hypothyroidism, hyperthyroidism, and their treatment on parameters of oxidative stress and antioxidant status. Clinical Chemistry and Laboratory Medicine 46 1004-1010. (doi:10.1515/CCLM.2008.183)
14. Erdamar H, Cimen B, Gülcemal H, Saraymen R, Yerer B &Demirci H 2010 Increased lipid peroxidation and impaired enzymatic antioxidant defense mechanism in thyroid tissue with multinodular goiter and papillary carcinoma. Clinical Biochemistry 43 650-654. (doi:10.1016/j.clinbiochem.2010.02.005)
15. Erel O 2004 A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clinical Biochemistry 37 277-285. (doi:10.1016/j.clinbiochem.2003.11.015)
16. Erel O 2005 A new automated colorimetric method for measuring total oxidant status. Clinical Biochemistry 38 1103-1111. (doi:10.1016/j.clinbiochem. 2005.08.008)
17. Fukuyo Y, Inoue M, Nakajima T, Higashikubo R, Horikoshi NT, Hunt C, Usheva A, Freeman ML & Horikoshi N 2008 Oxidative stress plays a critical role in inactivating mutant BRAF by geldanamycin derivatives. Cancer Research 68 6324-6330. (doi:10.1158/0008-5472.CAN-07-6602)
18. Harma M, Harma M & Erel O 2005 Oxidative stress in women with preeclampsia. American Journal of Obstetrics and Gynecology 192 656-657. (doi:10.1016/j.ajog.2004.07.085)
19. Ish-Shalom S, Durleshter L, Segal E & Nagler RM 2008 Sialochemical and oxidative analyses in radioactive I131-treated patients with thyroid carcinoma. European Journal of Endocrinology 158 677-681. (doi:10.1530/EJE-07- 0634)
20. Laatikainen LE, Castellone MD, Hebrant A, Hoste C, Cantisani MC, Laurila JP, Salvatore G, Salerno P, Basolo F, Näsman J et al. 2010 Extracellular superoxide dismutase is a thyroid differentiation marker down-regulated in cancer. Endocrine-Related Cancer 17 785-796. (doi:10.1677/ERC-10-0021)
21. Lassoued S, Mseddi M, Mnif F, Abid M, Guermazi F, Masmoudi H, El Feki A & Attia H 2010 A comparative study of the oxidative profile in Graves' disease, Hashimoto's thyroiditis, and papillary thyroid cancer. Biological Trace Element Research 138 107-115. (doi:10.1007/s12011-010-8625-1)
22. Lin JC, Kuo WR, Chiang FY, Hsiao PJ, Lee KW, Wu CW &Juo SH 2009 Glutathione peroxidase 3 gene polymorphisms and risk of differentiated thyroid cancer. Surgery 145 508-513. (doi:10.1016/j.surg.2008.12.008)
23. Liu B, Kuang A, Huang R, Zhao Z, Zeng Y, Wang J & Tian R 2010 Influence of vitamin C on salivary absorbed dose of 131I in thyroid cancer patients: a prospective, randomized, single-blind, controlled trial. Journal of Nuclear Medicine 51 618-623. (doi:10.2967/jnumed.109.071449)
24. Martinez-Cadenas C, Bosch N, Peñas L, Flores-Couce E, Ochoa E, Munárriz J, Aracil JP, Tajahuerce M, Royo R, Lozoya R et al. 2011 Malignant melanoma arising from a perianal fistula and harbouring a BRAF gene mutation: a case report. BMC Cancer 11 343. (doi:10.1186/1471-2407-11-343)
25. Mayer L, Romić Z, Skreb F, Bacić-Vrca V, Cepelak I, Zanić-Grubisić T & Kirin M 2004 Antioxidants in patients with hyperthyroidism. Clinical Chemistry and Laboratory Medicine 42 154-158. (doi:10.1515/CCLM.2004.028)
26. Nucera C, Lawler J, Hodin R & Parangi S 2010 The BRAFV600E mutation: what is it really orchestrating in thyroid cancer? Oncotarget 1 751-756. (doi:10.1634/theoncologist.2010-0317)
27. Nucera C, Nehs MA, Nagarkatti SS, Sadow PM, Mekel M, Fischer AH, Lin PS, Bollag GE, Lawler J, Hodin RA et al. 2011 Targeting BRAFV600E with PLX4720 displays potent antimigratory and anti-invasive activity in preclinical models of human thyroid cancer. Oncologist 16 296-309.
28. Saad-Hussein A, Hamdy H, Aziz HM & Mahdy-Abdallah H 2011 Thyroid functions in paints production workers and the mechanism of oxidative- antioxidants status. Toxicology and Industrial Health 27 257-263. (doi:10.1177/0748233710386409)
29. Santi A, Duarte MM, Moresco RN, Menezes C, Bagatini MD, Schetinger MR & Loro VL 2010 Association between thyroid hormones, lipids and oxidative stress biomarkers in overt hypothyroidism. Clinical Chemistry and Laboratory Medicine 48 1635-1639. (doi:10.1515/CCLM.2010.309)
30. Senthil N & Manoharan S 2004 Lipid peroxidation and antioxidants status in patients with papillary thyroid carcinoma in India. Asia Pacific Journal of Clinical Nutrition 13 391-395.
31. Torun AN, Kulaksizoglu S, Kulaksizoglu M, Pamuk BO, Isbilen E & Tutuncu NB 2009 Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism. Clinical Endocrinology 70 469-474. (doi:10.1111/j.1365-2265.2008.03348.x)
32. Uttara B, Singh AV, Zamboni P & Mahajan RT 2009 Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Current Neuropharmacology 7 65-74. (doi:10.2174/ 157015909787602823)
33. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M &Telser J 2007 Free radicals and antioxidants in normal physiological functions and human disease. International Journal of Biochemistry & Cell Biology 39 44-84. (doi:10.1016/j.biocel.2006.07.001)
34. Wells PG, McCallum GP, Chen CS, Henderson JT, Lee CJ, Perstin J, Preston TJ, Wiley MJ & Wong AW 2009 Oxidative stress in developmental origins of disease: teratogenesis, neurodevelopmental deficits, and cancer. Toxicological Sciences 108 4-18. (doi:10.1093/toxsci/kfn263)
35. Young O, Crotty T, O'Connell R, O'Sullivan J & Curran AJ 2010 Levels of oxidative damage and lipid peroxidation in thyroid neoplasia. Head & Neck 32 750-756. (doi:10.1002/hed.21247)